Aprogen KRX:007460KOSPI
에이프로젠 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days3
Articles tracked0since Sep 11
In Q2 2026, Aprogen reported revenue of ₩35.5bn, up 47.0% year on year, and an operating loss of ₩22.4bn. Aprogen (에이프로젠) appeared in 0 Korean news articles and 3 DART filings over the past seven days.
Aprogen quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩35.5bn | +47.0% | −₩22.4bn | −₩42.3bn |
| Q1 2026 | ₩36.3bn | +35.8% | −₩20.6bn | −₩28.1bn |
| Q4 2025 derived | ₩31.5bn | -20.5% | −₩26.9bn | −₩34.5bn |
| Q3 2025 | ₩35.6bn | -3.4% | −₩22.3bn | −₩33.7bn |
| Q2 2025 | ₩24.2bn | -32.1% | −₩23.9bn | −₩42.2bn |
| Q1 2025 | ₩26.7bn | -29.8% | −₩22.5bn | −₩30.1bn |
| Q4 2024 derived | ₩39.6bn | +6.0% | −₩29.1bn | −₩41.4bn |
| Q3 2024 | ₩36.8bn | -7.7% | −₩22.0bn | −₩21.9bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Aprogen top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Aprogen news Korean headlines
No articles yet.